Cardioprotective effects of zofenopril, enalapril and valsartan against ischaemia/reperfusion injury as well as doxorubicin cardiotoxicity

Autor: Evin Bozcali, Oner Suzer, Deniz B Dedeoglu, Vildan Karpuz, Hakan Karpuz

Publikováno v: Acta Cardiologica. 67:87-96

The aim of this study is to compare possible protective effects of zofenopril, enalapril and valsartan against both ischaemia/reperfusion injury as well as acute doxorubicin cardiotoxicity. All three agents have never been compared in this setting be

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb75028a0436b7bd3d8bf36fe0c54912
https://doi.org/10.1080/ac.67.1.2146570

Transgenic myocardial overexpression of prokineticin receptor-2 (GPR73b) induces hypertrophy and capillary vessel leakage

Autor: Stefan Frantz, Kyoji Urayama, Deniz B. Dedeoglu, Canan G. Nebigil, Nadia Messaddeq, Georg Ertl, Célia Guilini

Publikováno v: Cardiovascular Research
Cardiovascular Research, Oxford University Press (OUP), 2009, 81 (1), pp.28-37. ⟨10.1093/cvr/cvn251⟩
Cardiovascular Research, Oxford University Press (OUP), 2008, 81 (1), pp.28-37. ⟨10.1093/cvr/cvn251⟩
Cardiovascular Research, 2009, 81 (1), pp.28-37. ⟨10.1093/cvr/cvn251⟩

International audience; AIMS: Prokineticins are small secreted bioactive molecules. They exert their biological activity by binding to two G protein-coupled receptors. Previously, we have shown that the overexpression of prokineticin receptor-1 (PKR1

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ffcb55c57018cd9c1aab4e984f8c47f3
https://www.hal.inserm.fr/inserm-00370169